Does naringenin supplementation improve lipid profile, severity of hepatic steatosis and probability of liver fibrosis in overweight/obese patients with NAFLD? A randomised, double‐blind, placebo‐controlled, clinical trial
Keyword(s):
Keyword(s):
2010 ◽
Vol 9
◽
pp. 10-10
Keyword(s):
Keyword(s):
Keyword(s):
2017 ◽
Vol 10
(2)
◽
pp. 133-141
◽
Keyword(s):